Xenon Pharmaceuticals Inc.Xenon Pharmaceuticals Inc.Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.

No trades
See on Supercharts

Price target

57.130.000.00%
The 15 analysts offering 1 year price forecasts for XENE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 17 analysts giving stock ratings to XENE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


XENE EPS for the last quarter is −0.81 USD despite the estimation of −0.82 USD. In the next quarter EPS is expected to reach −0.85 USD. Track more of Xenon Pharmaceuticals Inc. financials and stay on top of what is up with the company.
In the next quarter Xenon Pharmaceuticals Inc. revenue is expected to reach ‪357.14 K‬ USD. Check out Xenon Pharmaceuticals Inc. revenue and earnings and make informed decisions.
According to analysts, XENE price target is 57.13 USD with a max estimate of 65.00 USD and a min estimate of 46.00 USD. Check if this forecast comes true in a year, meanwhile watch Xenon Pharmaceuticals Inc. stock price chart and keep track of the current situation with XENE news and stock market news.
We've gathered opinions of 17 analysts rating XENE stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.